tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARWR Stock Latest News

Arrowhead Pharmaceuticals Advances Plozasiran Study for Hypertriglyceridemia
Company AnnouncementsArrowhead Pharmaceuticals Advances Plozasiran Study for Hypertriglyceridemia
14d ago
ARWR
Arrowhead 9.265M share Block Trade priced at $19.00
PremiumThe Fly
Arrowhead 9.265M share Block Trade priced at $19.00
14d ago
ARWR
Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
PremiumThe Fly
Sarepta loses credibility by exiting Arrowhead at loss, says H.C. Wainwright
14d ago
ARWR
SRPT
Arrowhead redeems $50M of common stock
PremiumThe Fly
Arrowhead redeems $50M of common stock
14d ago
ARWR
SRPT
Arrowhead Pharmaceuticals: Positioned for Growth with Pivotal siRNA Program and Expanding Pipeline
PremiumRatings
Arrowhead Pharmaceuticals: Positioned for Growth with Pivotal siRNA Program and Expanding Pipeline
15d ago
ARWR
Arrowhead Pharmaceuticals’ Earnings Call Highlights Strategic Progress
PremiumCompany AnnouncementsArrowhead Pharmaceuticals’ Earnings Call Highlights Strategic Progress
16d ago
ARWR
Arrowhead Pharmaceuticals: Balancing Promising Launch Preparations with Pipeline Uncertainties
Premium
Ratings
Arrowhead Pharmaceuticals: Balancing Promising Launch Preparations with Pipeline Uncertainties
20d ago
ARWR
Arrowhead Pharmaceuticals Advances RNAi Therapeutics Pipeline
Premium
Company Announcements
Arrowhead Pharmaceuticals Advances RNAi Therapeutics Pipeline
20d ago
ARWR
Arrowhead Pharmaceuticals: Buy Rating Affirmed on Promising Pipeline and Late-Stage Developments
PremiumRatings
Arrowhead Pharmaceuticals: Buy Rating Affirmed on Promising Pipeline and Late-Stage Developments
20d ago
ARWR
Arrowhead reports Q3 EPS ($1.26), consensus ($1.10)
PremiumThe Fly
Arrowhead reports Q3 EPS ($1.26), consensus ($1.10)
20d ago
ARWR
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 Earnings Cheat Sheet
23d ago
ARWR
Arrowhead announces asset purchase agreement between Sanofi, Visirna
PremiumThe Fly
Arrowhead announces asset purchase agreement between Sanofi, Visirna
27d ago
SNY
ARWR
Strategic Collaboration with Sarepta Boosts Arrowhead Pharmaceuticals’ Buy Rating
PremiumRatingsStrategic Collaboration with Sarepta Boosts Arrowhead Pharmaceuticals’ Buy Rating
28d ago
ARWR
Cautious Hold Rating for Arrowhead Pharmaceuticals Amid SRPT Developments and Market Uncertainties
Premium
Ratings
Cautious Hold Rating for Arrowhead Pharmaceuticals Amid SRPT Developments and Market Uncertainties
29d ago
ARWR
Sarepta tells Bloomberg expects to honor Arrowhead commitments
Premium
The Fly
Sarepta tells Bloomberg expects to honor Arrowhead commitments
1M ago
ARWR
SRPT
Arrowhead earns $100M milestone payment from Sarepta
PremiumThe Fly
Arrowhead earns $100M milestone payment from Sarepta
1M ago
ARWR
SRPT
Arrowhead issues statement on exclusive license agreement with Sarepta
PremiumThe Fly
Arrowhead issues statement on exclusive license agreement with Sarepta
1M ago
ARWR
SRPT
Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Partnership with Sarepta Therapeutics
PremiumRatings
Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Partnership with Sarepta Therapeutics
1M ago
ARWR
Arrowhead falls -11.5%
PremiumThe Fly
Arrowhead falls -11.5%
1M ago
ARWR
Arrowhead falls -8.9%
PremiumThe FlyArrowhead falls -8.9%
1M ago
ARWR
Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
Premium
Ratings
Cautious Hold Rating on Arrowhead Pharmaceuticals Amid Uncertainty in Sarepta Partnership
1M ago
ARWR
Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
Premium
Company Announcements
Arrowhead Pharmaceuticals Advances Phase 3 Study of Zodasiran for Cholesterol Management
2M ago
ARWR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >